AHA Science

@ahascience.bsky.social

The official account for American Heart Association meetings, science news, funding opportunities and membership.

Registration Open: Early Intervention in HFpEF and HFmrEF: The Role of Finerenone in Improving Heart Failure Prognosis. 📅 Fri. Aug. 14 🕙 10am CDT 💻 Live webinar The Primary Care Perspectives: Heart Failure in Primary Care initiative is supported by Bayer. Register: https://bit.ly/4waiuji

Bild

That’s a wrap on #BCVS26! 🎉 Thank you to everyone who joined us, shared their science, and helped make this year’s meeting unforgettable. Mark your calendar for July 2027! #BCVS27 and Vascular Discovery are back-to-back next year in the beautiful Seaport district of Boston, Massachusetts!

Bild

The 2026 Guideline on the Management of Dyslipidemia was recently published. Here are the top things for clinicians using PREVENT-ASCVD Equations for Risk-Based Lipid Management.

 Here are the top things for clinicians using PREVENT-ASCVD Equations for Risk-Based Lipid Management. Here are the top things for clinicians using PREVENT-ASCVD Equations for Risk-Based Lipid Management. Here are the top things for clinicians using PREVENT-ASCVD Equations for Risk-Based Lipid Management. Here are the top things for clinicians using PREVENT-ASCVD Equations for Risk-Based Lipid Management.

Meet the authors of the 2026 ACC/AHA Dyslipidemia Guideline! Join us at 8 a.m. Thursday for an in-depth discussion of the updated recommendations in the new guideline – an update to the 2018 joint cholesterol guideline – and their implications for clinical practice. #EPILifestyle26

Meet the authors of the 2026 ACC/AHA Dyslipidemia Guideline!

Fuel your discoveries with funding, mentorship and the powerful research network of the American Heart Association. Don’t miss a chance to advance science and save lives. Applications are open.

Advancing science. Advancing you.

Advance your research with the support you deserve. We anticipate that about 1,000 grants will be awarded this year to help you advance science and save lives. Applications are open now.

Research Awards: fueling breakthroughs. Empowering you.

The TOP trial is a parallel, single-blind, randomized, clinical superiority trial, N=1424 that sought to determine whether liberal versus restrictive transfusion strategy after major general and vascular surgery reduces adverse outcomes in high cardiac risk patients. Sunil Rao, MD on the results.